Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

740
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
740
Cancer Therapies02:49

Cancer Therapies

8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel Therapeutic Approach: Gamma Secretase Inhibitor Enhances Radiotherapy and Checkpoint Blockade Therapy via Reprogramming of the Tumor Microenvironment.

bioRxiv : the preprint server for biology·2026
Same author

Seeing beyond CT: Multimodal Data and the Next Frontier of AI for Bone Metastasis Detection.

Radiology. Artificial intelligence·2026
Same author

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Nature·2026
Same author

Evolution of oncogene amplification across 86,000 cancer cell genomes.

bioRxiv : the preprint server for biology·2026
Same author

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer.

Nature communications·2025
Same author

Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology.

Nature communications·2025

Related Experiment Video

Updated: Oct 16, 2025

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
10:37

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

Published on: August 22, 2025

562

Harnessing multimodal data integration to advance precision oncology.

Kevin M Boehm1, Pegah Khosravi1, Rami Vanguri1

  • 1Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Nature Reviews. Cancer
|October 19, 2021
PubMed
Summary

Integrating multiple data types, like molecular, imaging, and clinical data, can enhance cancer precision oncology. Overcoming data sparsity is key to developing advanced multimodal biomarkers for future cancer care.

More Related Videos

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities
07:13

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities

Published on: October 27, 2023

1.4K
Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.1K

Related Experiment Videos

Last Updated: Oct 16, 2025

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
10:37

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

Published on: August 22, 2025

562
Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities
07:13

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities

Published on: October 27, 2023

1.4K
Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.1K

Area of Science:

  • Biomedical research
  • Computational biology
  • Precision oncology

Background:

  • Quantitative biomarker development has advanced cancer insights.
  • Current data-driven approaches often use single data modes, limiting integrated analysis.
  • Multimodal data integration offers potential for precision oncology beyond genomics.

Purpose of the Study:

  • To discuss the synthesis of complementary data modalities with multimodal artificial intelligence.
  • To highlight opportunities for advancing precision oncology through integrated data approaches.
  • To propose a future direction for developing novel multimodal biomarkers.

Main Methods:

  • Review and synthesis of current approaches in quantitative biomarker development.
  • Discussion of challenges in medical dataset sparsity for machine learning.
  • Exploration of multimodal artificial intelligence methods for heterogeneous data analysis.

Main Results:

  • Multimodal integration of molecular, imaging, and clinical data can advance precision oncology.
  • Significant challenges exist in data sparsity for training modern machine learning models.
  • Combined efforts in data engineering and computational methods are crucial.

Conclusions:

  • Synthesizing complementary data modalities with multimodal AI can create a new class of biomarkers.
  • Addressing data sparsity is essential for realizing the potential of multimodal data in oncology.
  • This integrated approach is poised to propel precision oncology in the next decade.